Newgeneharm. emerged as a global gene therapeutic company.

Newgenpharm announced to develop an anti-cancer therapy called "Theragene" jointly with Henry Ford Health system in the United States, mainly focusing on the new drugs for prostate and pancreatic cancers.

While keeping their business at a level of 10 billion won of annual sales, Newgenpharm tried to trim their generic drug lines more for a profit centered along with the new anti-cancer resea...